Society for the Advancement of Transplant Anesthesia

Dear SATA Members, You can now access SATA’s resources anywhere with the new SATA App, powered by C8 Health SATA is pleased to offer convenient access to relevant clinical resources for its members! SATA has partnered with C8 Health, a clinical resource management platform, to provide educational and clinical resources that can be accessed anywhere, and from any device. Designed by clinicians for clinicians, C8 Health will provide SATA members with an exclusive instance of the C8 Health app. This dedicated platform provides members with seamless access to clinical resources provided by SATA and keeps them updated on new guidelines and best practices. See the attached Q and A for more information. SATA Members Can: Stay up to date with the latest guidelines on Transplant Anesthesia. Seamlessly find and access SATA provided clinical resources and educational content. Easily access mobile-friendly materials directly at the point of care. Access documents through mobile-friendly formats and embedded tables of contents. Download now and log in with your email!

Shared post by SATA seed grant winner and Vanguard member, Dr. Elizabeth Townsend: Are you measuring IL-6 in Liver Transplant Donors and/or Recipients? What can this inflammatory cytokine tell us before, during, and after liver transplantation? Swipe to find out!

Reminder to share your experience on International survey: Management of DCD donors: A Global Comparison of Practice From the ILTS, SATA, and LICAGE. Thank you in advance. If you have any questions, please contact Dmitri Bezinover at [email protected].

Following the series of presenting publication by SATA members, this week we're presenting work done by Dr. Yoon and group at Thomas Jefferson University Hospital. Background: The study evaluates the impact of an ERAS protocol on living kidney donors. This randomized controlled trial (RCT) focuses on comparing the effectiveness of a comprehensive ERAS protocol with standard care in reducing postoperative opioid consumption and other outcomes. Methodology: Participants were recruited from an outpatient clinic, with 40 patients enrolled (23 in the ERAS group and 17 in the control group). The ERAS group received a 57-element intervention covering preoperative, intraoperative, and postoperative phases, including multimodal opioid-sparing pain management. In contrast, the control group received conventional care. Primary outcomes measured included postoperative opioid consumption, and secondary outcomes were pain scores, first oral intake, and hospital length of stay. Results: Primary Outcome: The ERAS group demonstrated significantly lower postoperative opioid consumption compared to the control group (24.2 ± 20.2 mg vs. 71 ± 39.5 mg morphine equivalents, P < 0.01). Secondary Outcomes: Postoperative pain scores were significantly lower in the ERAS group from 1 hour postoperatively to 48 hours. Surgical time was reduced by 45 minutes (P = 0.037). Time to tolerate a regular diet was 2.2 hours shorter (P = 0.008). Length of hospital stay was decreased by 10.1 hours. Intraoperative fluid administration was also lower in the ERAS group (P = 0.049). Conclusion: The study concluded that the ERAS protocol significantly reduced opioid consumption, improved pain management, and shortened hospital stays compared to standard care. The findings suggest that ERAS pathways can be effectively applied to living kidney donor surgeries to enhance recovery and minimize complications. Limitations: The study had a small sample size, and higher dropout rates in the control group affected secondary outcome reliability. Generalizability may be limited due to institution-specific protocol development and logistical considerations. This study highlights the benefits of adopting a comprehensive ERAS protocol for living kidney donor surgeries and provides a foundation for future research to optimize perioperative care and patient outcomes. Figured shared by permission from author.

SATA Annual Meeting started! #transplant #anestheisa

Study published in Transplantation online by researchers at Henry Ford hospital on “Successful Implementation of a Multidisciplinary Weight Loss Program Including GLP1 Receptor Agonists for Liver Transplant Candidates With High Body Mass Index”: **Background:** - Problem: BMI >40 as a relative contraindication for liver transplant. - **Hypothesis:** Multidisciplinary support and glucagon-like protein 1 receptor agonists facilitate necessary weight loss. **Methods:** - Participants: Patients 18+ with BMI >40 or >35 with complicating abdominal adiposity. - Interventions: Individualized support from hepatologists, dieticians, counselors, and anti-obesity medication. **Results:** - Sample Size: 19 patients - Baseline BMI: Median 42 - Median Weight Loss: 11.7 kg - Transplants: 8 received, 4 waitlisted - Treatment: GLP-1 receptor agonists (liraglutide, semaglutide, tirzepatide), phentermine **Conclusions:** - High BMI patients benefit from tailored dietary and medical support to achieve liver transplant eligibility. **Citation:** Transplantation ():10.1097/TP.0000000000005070, May 17, 2024. | DOI: 10.1097/TP.0000000000005070 Disclaimer: Artwork generated by ChatGPT 4o

#ILTS2024 #Houston Many SATA leaders and members participate and present their excellent studies today during ILTS2024.

Only 1 month until annual SATA symposium in Seattle. Date: Sunday May 19 to Monday May 20, 2024 Location: Hyatt Regency Seattle Hotel, 5th floor, Room 502; 808 Howell St, Seattle, WA 98101 Registration (with CME credit): https://buff.ly/3vkc9bH $50 for SATA, SOCCA and SCA members, $150 for non-members, free for trainees SATA Council meeting on May 1, 2024, at 6 PM

Point of Care Ultrasound (#PoCUS) & TEE for the #LiverTransplant #Anesthesiologist Monday May 20, 2024 from 8:00 am to 10:00 am Hyatt Regency Seattle Hotel, 5th floor, Room 502; 808 Howell St, Seattle, WA 98101 Registration Link: https://lnkd.in/eJbKfv2C

Point of Care Ultrasound (#PoCUS) & TEE for the #LiverTransplant #Anesthesiologist Monday May 20, 2024 from 8:00 am to 10:00 am Hyatt Regency Seattle Hotel, 5th floor, Room 502; 808 Howell St, Seattle, WA 98101 Registration Link: https://lnkd.in/eAsHM_GJ